FDA’s Summer Plans May Include LDT Rulemaking
FDA Law Blog
JUNE 19, 2023
And regulating LDTs through guidance documents is vulnerable to legal challenge on procedural grounds. Rulemaking avoids the twin problems of dependency on action by Congress and the legal weakness of imposing substantive legal requirements through guidance. And, of course, there is the political calendar.
Let's personalize your content